Search Ontology:
ChEBI
beta-D-Galp-(1->4)-[beta-D-Galp-(1->4)-beta-D-Glcp-(1->6)]-beta-D-GlcpNAc-O[CH2]3NH3(+)
- Term ID
- CHEBI:145696
- Synonyms
-
- 3-ammoniopropyl 2-acetamido-4-O-beta-D-galactopyranosyl-6-O-[4-O-(beta-D-galactopyranosyl)-beta-D-glucopyranosyl]-2-deoxy-beta-D-glucopyranoside
- 3-ammoniopropyl beta-D-galactosyl-(1->4)-[beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1->6)]-N-acetyl-beta-D-glucosaminide
- 3-ammoniopropyl beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1->6)-[beta-D-galactosyl-(1->4)]-N-acetyl-beta-D-glucosaminide
- 3-azaniumylpropyl 2-acetamido-4-O-beta-D-galactopyranosyl-6-O-[4-O-(beta-D-galactopyranosyl)-beta-D-glucopyranosyl]-2-deoxy-beta-D-glucopyranoside
- 3-azaniumylpropyl beta-D-galactosyl-(1->4)-[beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1->6)]-N-acetyl-beta-D-glucosaminide
- 3-azaniumylpropyl beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1->6)-[beta-D-galactosyl-(1->4)]-N-acetyl-beta-D-glucosaminide
- 3-{[beta-D-galactopyranosyl-(1->4)-[beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranosyl-(1->6)]-2-acetamido-2-deoxy-beta-D-glucopyranosyl]oxy}propan-1-aminium
- 3-{[beta-D-galactosyl-(1->4)-[beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1->6)]-N-acetyl-beta-D-glucosaminyl]oxy}propan-1-aminium
- beta-D-Gal-(1->4)-[beta-D-Gal-(1->4)-beta-D-Glc-(1->6)]-beta-D-GlcNAc-O[CH2]3NH3(+)
- beta-D-Gal-(1->4)-beta-D-Glc-(1->6)-[beta-D-Gal-(1->4)]-beta-D-GlcNAc-O[CH2]3NH3(+)
- Galbeta1-4(Galbeta1-4Glcbeta1-6)GlcNAcbetaO[CH2]3NH3(+)
- Galbeta1-4Glcbeta1-6(Galbeta1-4)GlcNAcbetaO[CH2]3NH3(+)
- Definition
- A glycoside that is beta-D-Gal-(1->4)-[beta-D-Gal-(1->4)-beta-D-Glc-(1->6)]-beta-D-GlcNAc in which the hydroxy group at the reducing-end anomeric centre is replaced by a 3-azaniumylpropyl group.
- References
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_functional_parent
-
Phenotype
Phenotype resulting from beta-D-Galp-(1->4)-[beta-D-Galp-(1->4)-beta-D-Glcp-(1->6)]-beta-D-GlcpNAc-O[CH2]3NH3(+)
Phenotype where environments contain beta-D-Galp-(1->4)-[beta-D-Galp-(1->4)-beta-D-Glcp-(1->6)]-beta-D-GlcpNAc-O[CH2]3NH3(+)
Phenotype modified by environments containing beta-D-Galp-(1->4)-[beta-D-Galp-(1->4)-beta-D-Glcp-(1->6)]-beta-D-GlcpNAc-O[CH2]3NH3(+)
Human Disease Model